AI
OLMA icon

Atom Investors’s Olema Pharmaceuticals OLMA Stock Holding History

Atom Investors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,499
Closed -$50.8K – 740
2025
Q1 		$50.8K Buy
+13,499
New +$67.9K 0.01% 468
2024
Q3 		– Sell
-34,515
Closed -$373K – 568
2024
Q2 		$373K Sell
34,515
-59,806
-63% -$649K 0.04% 354
2024
Q1 		$1.07M Buy
94,321
+35,451
+60% +$457K 0.13% 217
2023
Q4 		$826K Buy
+58,870
New +$791K 0.15% 206
2021
Q1 		– Sell
-25,399
Closed -$1.22M – 378
2020
Q4 		$1.22M Buy
+25,399
New +$1.19M 0.12% 177

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Atom Investors's OLMA Position: Q2 2025 in Review

Atom Investors sold out of Olema Pharmaceuticals (OLMA) in Q2 2025, closing a stake of 13,499 shares — an estimated $50.8K sold.

Atom Investors first reported a position in OLMA in Q4 2020 and held it in 5 quarters. The position peaked at $1.22M in Q4 2020. 122 funds tracked by Wall St. Rank hold OLMA as of Q2 2025.

  • Atom Investors reported no remaining Olema Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Atom Investors sold 13,499 Olema Pharmaceuticals shares in Q2 2025, an estimated $50.8K.
  • Atom Investors first reported a position in Olema Pharmaceuticals in Q4 2020 and held it in 5 quarters.
  • Atom Investors's Olema Pharmaceuticals position peaked at $1.22M in Q4 2020.
  • 122 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2025.

Based on Atom Investors's 13F filing for Q2 2025, filed 14 Aug 2025.